Evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the Brazilian Public Health System

Einstein (Sao Paulo). 2020 Nov 20:18:eCE5754. doi: 10.31744/einstein_journal/2020CE5754. eCollection 2020.

[Article in English, Portuguese]

Authors

Charleston Ribeiro Pinto^{1

2

3}, Lindemberg Assunção Costa^{1

3}, Antônio Carlos Moreira Lemos³, Eduardo Martins Netto³

Affiliations

¹ Faculdade de Farmácia, Universidade Federal da Bahia, Salvador, BA, Brazil.
² Curso de Farmácia, Universidade Estadual do Sudoeste da Bahia, Jequié, BA, Brazil.
³ Complexo Hospitalar Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, BA, Brazil.

PMID: 33237247
PMCID: PMC7664825
DOI: 10.31744/einstein_journal/2020CE5754

No abstract available

Publication types

Letter

MeSH terms

Brazil
Drugs, Essential*
Health Policy*
Health Services Accessibility*
Humans
Public Health
Pulmonary Disease, Chronic Obstructive / drug therapy*

Substances

Drugs, Essential